Rapid Expansion at Helix 51 Highlights Fifth Anniversary
Helix 51 celebrated its fifth year of operations in April with the entry of four new companies, bringing the biomedical…
News Archive
CLEAR Celebrates 20 Years
In an unassuming space in the corner of the RFU Health Sciences Building’s Garden Level, Dr. William M. Scholl College…
Helix 51 Biomedical Incubator Celebrates 5 Years Supporting Research Startups
Rosalind Franklin University’s Helix 51 biomedical incubator celebrated earlier this year five…
RFU, DePaul Research Collaborations Target Killer Diseases
Malaria, cigarette smoking and septic shock kill millions of people every year. In a fresh round of funding, RFU and…
Rosalind Franklin University Researchers Selected as 2024 “Illinois Researchers to Know”
Three RFU research faculty have been named among “Illinois Researchers to Know” by the Illinois…
Helix 51 Biomedical Incubator Marks Fifth Anniversary, Rapid Expansion
RFU's Helix 51 biomedical incubator, the only one of its kind in Lake County, Illinois, celebrated its fifth year of…
FDA Grants Orphan Drug Designation for Treatment of Scleroderma Developed by Helix 51's BLR Bio
The U.S. Food and Drug Administration (FDA) granted an Orphan Drug Designation for an investigational…
Through the Microscope: Community-Engaged Research - The Collaborative Path to Health Equity
Research is a practice that can be an embodied1 approach to make change in the world, giving attention…
$8.1 Million in Illinois Board of Higher Education Capital Funds Targeted for Enhancements to Simulation Facilities, IRP
Capital funds provided by the state of Illinois will help RFU build a virtual health system, expand…
New Findings on Natural Killer (NK) Cells as Cancer Therapy for Glioblastoma, Leukemia and Lymphoma Published by Helix 51 Incubator Company
Artec Biotech, a company in RFU’s Helix 51 Incubator, is developing a potentially promising treatment…